Related Experiment Video
Updated: May 28, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
An Analysis of Print and Online Media's Representation of Prostate Cancer in Public Figures
Angelo Blancaflor1, Katherine Danaher2, Jacob Lally2
1The Minimally Invasive Urology Institute at The Miriam Hospital, Division of Urology, Warren Alpert Medical School of Brown University, Providence, RI, USA. angelo_blancaflor@brown.edu.
Abstract:
Print and online media play a crucial role in shaping public understanding of diseases like prostate cancer (PCa), particularly through reporting on public figures. However, such media coverage can introduce bias by providing incomplete or non-evidence-based information. This study aimed to assess potential bias by applying a standardized rubric to articles discussing PCa in public figures. Articles were sourced from LexisNexis® using the terms "prostate cancer" and the name of a public figure diagnosed with the disease. The study analyzed 147 articles covering 49 public figures, selected based on relevance from top-circulation publications between 1994 and 2024. Of these, 95.9% had unbiased titles, 35.4% included expert quotes, and 27.2% mentioned risk factors such as age, race, and family history. However, 25.9% of the articles exhibited bias supporting PCa screening, and only 16.3% referenced scientific studies. Additionally, among the 45 articles published when shared decision-making (SDM) was the standard of care for screening decisions, only one referenced this concept. Thus, while titles were generally unbiased, statements supporting screening, low rates of scientific referencing, and minimal reference to SDM highlight limitations of this reporting that may bias readers' understanding of prostate cancer detection and treatment. These findings may provide a window into how reporting on medical conditions in public figures, which can influence readers' perceptions of disease, can improve in quality and completeness.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Cancer Survival Analysis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Abnormal Proliferation
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...